<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We used a highly specific method, alkaline methanolysis-high performance liquid chromatography, for determining the concentration and patterns of the unconjugated and esterified <z:chebi fb="0" ids="16990">bilirubin</z:chebi> fractions in the sera of pediatric patients with <z:e sem="disease" ids="C0267792" disease_type="Disease or Syndrome" abbrv="">hepatobiliary disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="16990">Bilirubin</z:chebi>-protein conjugates were assayed using a new method that selectively removes <z:chebi fb="0" ids="16990">bilirubin</z:chebi> reversibly bound to protein, allowing measurement of the tightly bound <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-protein conjugates by use of a <z:chebi fb="1" ids="30105">diazo</z:chebi> method </plain></SENT>
<SENT sid="2" pm="."><plain>Fifty-two serum samples from children with varying <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations and diagnoses were studied </plain></SENT>
<SENT sid="3" pm="."><plain>Whereas no conjugated pigment was detectable in the serum samples of healthy children or in individuals with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> or <z:e sem="disease" ids="C0010324" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome</z:e>, <z:chebi fb="0" ids="16990">bilirubin</z:chebi> monoester and <z:chebi fb="0" ids="51307">diester</z:chebi> conjugates and <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-protein conjugates were present in the sera of children with <z:hpo ids='HP_0002611'>cholestatic liver disease</z:hpo>, and accounted for 69% +/- 15% of the total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in these samples </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="16990">Bilirubin</z:chebi> fractional analysis was incapable of differentiating <z:e sem="disease" ids="C0005398" disease_type="Disease or Syndrome" abbrv="">extrahepatic biliary obstruction</z:e> from hepatocellular disease, because of overlap between the groups </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-protein conjugates in serum always coincided with detection of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> monoester and <z:chebi fb="0" ids="51307">diester</z:chebi> conjugates </plain></SENT>
<SENT sid="6" pm="."><plain>The distribution of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> and its conjugates in sera provides a sensitive, although nonspecific, measure of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatic disease</z:e> </plain></SENT>
</text></document>